Measurable residual disease assessment in apheresis product from multiple myeloma patients: Correlation with biology, depth of response and survival.

Puertas B, Padilla I, Alejo E, Serra-Toral F, García-Mateo A, López-López R, Bárez A, Alonso-Alonso JM, Aguilar-Franco C, de Cabo E, Cantalapiedra-Diez A, García-Coca A, Hernández R, Rey-Búa B, Fonseca-Santos M, López-Parra M, López-Corral L, Gutiérrez NC, Vidriales-Vicente MB, Pérez JJ, González-Calle V, Mateos MV, Escalante F, Flores-Montero J, Puig N

Open source

DOI: 10.1111/bjh.70606
Published: 2026 Aug
Container: British journal of haematology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1111/bjh.70606,
  title = {Measurable residual disease assessment in apheresis product from multiple myeloma patients: Correlation with biology, depth of response and survival.},
  author = {Puertas B and Padilla I and Alejo E and Serra-Toral F and García-Mateo A and López-López R and Bárez A and Alonso-Alonso JM and Aguilar-Franco C and de Cabo E and Cantalapiedra-Diez A and García-Coca A and Hernández R and Rey-Búa B and Fonseca-Santos M and López-Parra M and López-Corral L and Gutiérrez NC and Vidriales-Vicente MB and Pérez JJ and González-Calle V and Mateos MV and Escalante F and Flores-Montero J and Puig N},
  year = {2026},
  journal = {British journal of haematology},
  doi = {10.1111/bjh.70606},
  url = {https://doi.org/10.1111/bjh.70606}
}

RIS

TY  - JOUR
TI  - Measurable residual disease assessment in apheresis product from multiple myeloma patients: Correlation with biology, depth of response and survival.
AU  - Puertas B
AU  - Padilla I
AU  - Alejo E
AU  - Serra-Toral F
AU  - García-Mateo A
AU  - López-López R
AU  - Bárez A
AU  - Alonso-Alonso JM
AU  - Aguilar-Franco C
AU  - de Cabo E
AU  - Cantalapiedra-Diez A
AU  - García-Coca A
AU  - Hernández R
AU  - Rey-Búa B
AU  - Fonseca-Santos M
AU  - López-Parra M
AU  - López-Corral L
AU  - Gutiérrez NC
AU  - Vidriales-Vicente MB
AU  - Pérez JJ
AU  - González-Calle V
AU  - Mateos MV
AU  - Escalante F
AU  - Flores-Montero J
AU  - Puig N
PY  - 2026
JO  - British journal of haematology
DO  - 10.1111/bjh.70606
UR  - https://doi.org/10.1111/bjh.70606
ER  -

APA

B, P., I, P., E, A., F, S., A, G., R, L., A, B., JM, A., C, A., E, D. C., A, C., A, G., R, H., B, R., M, F., M, L., L, L., NC, G., MB, V., JJ, P., V, G., MV, M., F, E., J, F., & N, P. (2026). Measurable residual disease assessment in apheresis product from multiple myeloma patients: Correlation with biology, depth of response and survival.. British journal of haematology. https://doi.org/10.1111/bjh.70606

Source records

pubmed · retrieved 2026-09-25T16:20:46.496Z